DNLI Competitors & Alternatives
Compare Denali Therapeutics Inc with similar stocks in the same industry
Biotechnology
DNLI
Main Stock$19.24
Tradestie Score
58
Market Cap
$2.18B
Revenue Growth
-1.0%
Analyst Upside
+84.9%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NAMS
NewAmsterdam Pharma Company N.V. Ordinary Shares
|
$37.38
|
$3.31B | - | 61 | Compare |
|
SLNO
Soleno Therapeutics, Inc. Common Stock
|
$52.99
|
$3.20B | 27.4 | 44 | Compare |
|
MLYS
Mineralys Therapeutics, Inc. Common Stock
|
$26.87
|
$3.09B | - | 58 | Compare |
|
VKTX
Viking Therapeutics, Inc
|
$31.41
|
$3.08B | - | 50 | Compare |
|
CNTA
Centessa Pharmaceuticals plc American Depositary Shares
|
$39.58
|
$3.03B | - | 56 | Compare |
|
XENE
Xenon Pharmaceuticals Inc
|
$55.34
|
$3.02B | - | 58 | Compare |
|
CGON
CG Oncology, Inc. Common stock
|
$68.89
|
$3.01B | - | 61 | Compare |
|
APLS
Apellis Pharmaceuticals, Inc. Common Stock
|
$41.03
|
$2.92B | 38.3 | 59 | Compare |
|
RARE
Ultragenyx Pharmaceutical Inc.
|
$26.08
|
$2.89B | - | 61 | Compare |
|
IMVT
Immunovant, Inc. Common Stock
|
$28.68
|
$2.85B | - | 65 | Compare |
More DNLI Analysis
Data updated: May 14, 2026 | Industry: Biotechnology (SIC 2836)
228 stocks in this industry